Quick Answer
Bionano Genomics, Inc. reported Common Stock Shares Outstanding of 10.74 million shares for the year ending 2025.
- Bionano Genomics, Inc. showed an increase of +475.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Bionano Genomics, Inc.'s Common Stock Shares Outstanding has grown by 13,801.9%.
- Historical annual values: Fiscal year 2025: 10.74 million shares | Fiscal year 2024: 1.87 million shares | Fiscal year 2023: 762,533 shares | Fiscal year 2022: 29.72 million shares | Fiscal year 2021: 289.60 million shares | Fiscal year 2020: 189.95 million shares | Fiscal year 2019: 34.27 million shares | Fiscal year 2018: 10.06 million shares | Fiscal year 2017: 77,257 shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: